No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

ICI’s New Biorisk Cloud Platform Helps Organizations Protect their Workforces from Biorisk Threats

Editor: What To Know

  • According to the CDC, fever is the most common symptom of COVID-19 and is present in nearly 80% of cases.
  • Combining infrared technology and a proprietary, cloud-based data management solution, ICI helps organizations across industries report and manage biorisk, such as COVID-19, to avoid potential safety incidents and operational disruptions.
  • With accurate, real-time temperature readings, ICI's platform streams data from thermal cameras to ICI's proprietary cloud platform to identify biorisk patterns and threats before they cause operational issues like facility closures or shuttering of distribution centers.

To help businesses, agencies and healthcare providers protect their people from biorisk threats, Infrared Cameras Incorporated (ICI) today unveiled its new Biorisk Cloud Platform.

Combining infrared technology and a proprietary, cloud-based data management solution, ICI helps organizations across industries report and manage biorisk, such as COVID-19, to avoid potential safety incidents and operational disruptions.

With accurate, real-time temperature readings, ICI’s platform streams data from thermal cameras to ICI’s proprietary cloud platform to identify biorisk patterns and threats before they cause operational issues like facility closures or shuttering of distribution centers. The cloud platform, supported by Amazon Web Services, can be readily integrated into an organization’s current business intelligence and operational platforms to help enhance reporting and improve safety and operational processes.

“Throughout the COVID-19 pandemic, organizations have realized tens of millions of lost operational hours due to outbreaks within their facilities,” said Gary Strahan, Chief Executive Officer at ICI. “Unfortunately, with new variants, including the extremely contagious Omicron variant, organizations will continue to be at risk of COVID-19 outbreaks within their facilities for years to come. Fortunately, ICI has developed a solution.”

According to the CDC, fever is the most common symptom of COVID-19 and is present in nearly 80% of cases. Through immediate, accurate identification of febrile individuals, organizations are able to mitigate exposure to COVID-19 and other infectious diseases.

“With nearly 90% of workers admitting to going to work while potentially infectious, outbreaks within organizations have become commonplace. These outbreaks lead to employee downtime, lower outputs, and a negative impact to an organization’s bottom line. Our platform helps organizations keep their people safe and their operations running smoothly,” said Strahan.

Texas Children’s Hospital, one of the largest and most comprehensive specialty pediatric hospitals in the U.S., is using ICI’s Biorisk Cloud Platform for temperature screening across its hospital, clinic and specialty care center locations.

“Providing extra protection for everyone in our facilities, we have deployed thirty cameras for screening employees across our buildings, tracking temperatures to help prevent anyone with COVID-19 from entering,” said Bert Gumeringer, Senior Vice President of Facilities Operations, Texas Children’s Hospital. “This type of screening is now a way of life. ICI is making it a smooth and efficient process for us and employee response has been fantastic.”

ICI’s platform is catered to an organization’s structure and processes, allowing them to communicate the most relevant data to each user.

Key features of the platform include:

  • Real-time, automated notifications;

  • Multifaceted analytics;

  • Customizable dashboards;

  • Ability to set benchmarks and identify deviations before they cause disruptions; and

  • Seamless integration with your organization’s current systems and processes including most access control and VM systems proprietary AI algorithms.

From design and implementation to calibration and training, ICI expert technicians service and educate customers every step of the way.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy